In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Ileana Pina
Speaker
Ileana Pina
Ileana Pina Ileana Pina

Wayne State University, Detroit (United States of America)

Specialities : Acute Heart Failure , Chronic Heart Failure, Device Therapy, Pharmacology and Pharmacotherapy

Write your professional biography here ... Professor of Medicine Wayne State University Clinical Professor Central Michigan University Senior Staff Fellow FDA, CDRH, Medical Officer

17 presentations from this speaker

Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?

Event : HFA Discoveries 2020

  • Session : Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?
  • Speaker : P Ponikowski (Wroclaw,PL), A Coats (Warwickshire,GB), I Pina (Detroit,US), M Kosiborod (Kansas,US), M Crespo-Leiro (La Coruna,ES)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre Sponsored by an unrestricted educational grant from AstraZeneca

Medical devices and big data.

Event : Heart Failure 2019

  • Session : The future of big data strategies in heart failure
  • Speaker : I Pina (Detroit,US)

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

Event : Heart Failure 2019

  • Session : Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy
  • Speaker : I Pina (Detroit,US)
  • Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

The failing heart of a woman – just more of the same?

Event : ESC Congress 2019

  • Session : Female patients and female physicians. Does it make any difference?
  • Speaker : I Pina (Detroit,US)
  • Promoted by Women in ESC

Advances in hyperkalaemia management – overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Event : ESC Congress 2018

  • Session : Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
  • Speaker : I Pina (Detroit,US)
  • Organised by Charité supported with an educational grant from Vifor

Disease management programmes to improve outcome in heart failure

Event : ESC Congress 2018

  • Session : Expert Advice - How to prevent readmissions in patients with acute heart failure
  • Speaker : I Pina (Detroit,US)

Panel discussion and close - Hyperkalaemia and iron deficiency: time for a paradigm change.

Event : ESC Congress 2018

  • Session : Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
  • Speaker : J Butler (Atlanta,US), G Filippatos (Athens,GR), S Anker (Berlin,DE), P Van Der Meer (Groningen,NL), I Pina (Detroit,US)
  • Organised by Charité supported with an educational grant from Vifor

“Wet and cold” patient.

Event : Heart Failure 2017

  • Session : Challenging clinical scenarios in acute heart failure
  • Speaker : I Pina (Detroit,US)

Pulmonary disease.

Event : Heart Failure 2016

  • Session : Exercise training: for whom, when and how?
  • Speaker : I Pina (Detroit,US)

New pharmacological options for heart failure.

Event : ESC Congress 2015

  • Session : New paradigms in heart failure: RAAS inhibition and the management of hyperkalemia
  • Speaker : I Pina (Detroit,US)
  • Sponsored by ZS Pharma, Inc.

Panel Discussion - New paradigms in heart failure: RAAS inhibition and the management of hyperkalemia.

Event : ESC Congress 2015

  • Session : New paradigms in heart failure: RAAS inhibition and the management of hyperkalemia
  • Speaker : JJV McMurray (Glasgow,GB), F Zannad (Vandoeuvre,FR), I Pina (Detroit,US)
  • Sponsored by ZS Pharma, Inc.

Questions and answers - New paradigms in heart failure: RAAS inhibition and the management of hyperkalemia.

Event : ESC Congress 2015

  • Session : New paradigms in heart failure: RAAS inhibition and the management of hyperkalemia
  • Speaker : JJV McMurray (Glasgow,GB), F Zannad (Vandoeuvre,FR), I Pina (Detroit,US)
  • Sponsored by ZS Pharma, Inc.

Should we use high intensity exercise?

Event : ESC Congress 2014

  • Session : Controversies in exercise training in heart failure
  • Speaker : I Pina (Detroit,US)

The RAASi Debate – Team #1 Arguments: RAASI should continue in HF and CKD patients.

Event : ESC Congress 2014

  • Session : The RAASi debate: should RAAS blockade continue with a declining eGFR?
  • Speaker : I Pina (Detroit,US), F Locatelli (Lecco,IT)
  • Sponsored by ZS Pharma, Inc.

The RAASi Debate – Team #1 challenges team #2

Event : ESC Congress 2014

  • Session : The RAASi debate: should RAAS blockade continue with a declining eGFR?
  • Speaker : I Pina (Detroit,US), F Locatelli (Lecco,IT)
  • Sponsored by ZS Pharma, Inc.

Physical exercise and pharmacotherapy to treat depression.

Event : ESC Congress 2013

  • Session : New frontiers in behavioural interventions
  • Speaker : I Pina (Detroit,US)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are